U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
66Y330CJHS
Other
General
Names
2
Classification
6
Related Substances
1
IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
66Y330CJHS
Other
General
Approval Year
Unknown
86,413
Names
2
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
Common Name
English
IMMUNEGLOBULIN INTRAVENOUS (HUMAN)
Common Name
English
Showing 1 to 2 of 2 entries
Previous
1
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of polymyositis/dermatomyositis.
FDA ORPHAN DRUG
68992
Designated
ORPHAN DRUG
Designated
Treatment of systemic sclerosis
FDA ORPHAN DRUG
720719
Designated
ORPHAN DRUG
Designated
Treatment for Guillain Barre Syndrome
FDA ORPHAN DRUG
184704
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of patients with acute myocarditis.
FDA ORPHAN DRUG
75893
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Human Immunoglobulin G
[EPC]
NDF-RT
N0000184165
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Related Substances
1
SUBSTANCE RECORD
IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
